Eva Arranz
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 7
- Genetics 8
- Chronic Lymphocytic Leukemia Research 4
- Genomic variations and chromosomal abnormalities 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Javier Benı́tez (13 shared papers)Carmen Rivas (8 shared papers)Mercedes Robledo (10 shared papers)Beatriz Martínez–Delgado (5 shared papers)María J. García (3 shared papers)Françesc Solé (2 shared papers)Marı́a José Calasanz (2 shared papers)José Cervera (2 shared papers)
- Journals
- Leukemia (3 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)Genes Chromosomes and Cancer (1 paper)PLoS ONE (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
Eva Arranz
23 papers receiving 535 citations
Peers
Comparison fields: 5 of 38
- Hematology 248
- Genetics 153
- Pathology and Forensic Medicine 209
- Cancer Research 62
- Oncology 107
Countries citing papers authored by Eva Arranz
This map shows the geographic impact of Eva Arranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Arranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Arranz more than expected).
Fields of papers citing papers by Eva Arranz
This network shows the impact of papers produced by Eva Arranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Arranz. The network helps show where Eva Arranz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Arranz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. | 2005 | 130 |
| 2 | 1997 | 71 | |
| 3 | Genetic instability of microsatellites in hematological neoplasms. | 1995 | 60 |
| 4 | Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia. | 2003 | 34 |
| 5 | 1997 | 33 | |
| 6 | 1998 | 33 | |
| 7 | 2003 | 29 | |
| 8 | 2012 | 26 | |
| 9 | 2001 | 26 | |
| 10 | 2013 | 23 | |
| 11 | 1998 | 18 | |
| 12 | A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot. | 1997 | 16 |
| 13 | 1996 | 15 | |
| 14 | 2006 | 13 | |
| 15 | 2018 | 6 | |
| 16 | 1997 | 3 | |
| 17 | 1997 | 2 | |
| 18 | 2000 | 2 | |
| 19 | 2020 | 1 | |
| 20 | 2002 | 1 |
About Eva Arranz
Eva Arranz is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Genetics, having authored 24 papers that have together received 545 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Genomic variations and chromosomal abnormalities (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Hematology (248 citations), Genetics (153 citations), Pathology and Forensic Medicine (209 citations), Cancer Research (62 citations) and Oncology (107 citations). Eva Arranz has collaborated with scholars based in Spain and United States. Frequent co-authors include Javier Benı́tez, Carmen Rivas, Mercedes Robledo, Beatriz Martínez–Delgado, María J. García, Françesc Solé, Marı́a José Calasanz, José Cervera, Juan C. Cigudosa and Guillermo Sanz. Their work appears in journals such as Leukemia, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Genes Chromosomes and Cancer, PLoS ONE and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.